Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalent	$ 25,499,635	$ 4,923,515
Restricted cash	751,625
Accounts receivable	132,827	109,366
Deferred offering costs		33,164
Insurance deposits	1,749,454	749,454
Other current assets	644,099	313,812
Total current assets	28,777,640	6,129,311
Property and equipment, net	7,624	8,425
Intangible assets, net	61,562	80,031
Other assets		95,000
Total assets	28,846,826	6,312,767
Current liabilities:
Accounts payable	4,497,276	2,275,559
Accrued liabilities	826,724	4,359,348
Insurance reserve	1,747,134	2,113,039
Note payable, current portion	1,890,062	1,554,548
Deferred revenue	60,056	76,059
Total current liabilities	9,021,252	10,378,553
Note payable, net of current portion	109,113	444,627
Total liabilities	9,130,365	10,823,180
Commitments and contingencies (Note 3)
Stockholders' equity (deficit):
Preferred stock, 15,000,000 shares authorized, par value $0.00001, 0 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively
Common stock, 50,000,000 shares authorized, par value $0.00001, 20,353,429 and 17,741,713 issued and outstanding as of March 31, 2021 and December 31, 2020, respectively	203	177
Additional paid-in capital	71,158,828	39,725,445
Accumulated deficit	(51,442,570)	(44,236,035)
Total stockholders' equity (deficit)	19,716,461	(4,510,413)
Total liabilities and stockholders' equity (deficit)	$ 28,846,826	$ 6,312,767